GENI vs OPRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

GENI

47.6
AI Score
VS
GENI Wins

OPRA

40.2
AI Score

Investment Advisor Scores

GENI

48score
Recommendation
HOLD

OPRA

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GENI OPRA Winner
Forward P/E 62.5 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 64.7% 24.6% GENI
Earnings Growth 0.0% 76.5% OPRA
Tradestie Score 47.6/100 40.2/100 GENI
Profit Margin -23.0% 18.6% OPRA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GENI 1M: -10.8% · 3M: -3.0% OPRA 1M: -8.0% · 3M: +3.0%

Current Technical Phase

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.8 · Price: $6.82

OPRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.7 · Price: $18.30

Fundamentals Snapshot

Metric GENI OPRA
Market Cap
Forward P/E 6.4 10.2
Trailing P/E 12.8
Revenue (TTM)
Revenue Growth 0.6% 0.2%
Gross Margin 0.3% 0.5%
Operating Margin -0.1% 0.2%
EPS -0.64 1.41
Dividend Yield 0.05%

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.